Literature DB >> 2409871

Hb F production in stressed erythropoiesis: observations and kinetic models.

G Stamatoyannopoulos, R Veith, R Galanello, T Papayannopoulou.   

Abstract

The mechanism of stimulation of Hb F in stressed erythropoiesis is examined. Conditions known to produce a transient elevation of F-cells (acute anemia; acute expansion; treatment with cytotoxic compounds) have a common element, the acute kinetic perturbations of erythroid differentiation/maturation they trigger. Cell cycling must be shortened and the total time of differentiation (from BFUe to erythroblast) must be shortened. We propose that F-cells are formed either because of the shortening of erythroid differentiation time or because of shortening of cell cycle of erythroid cells. With the model of shortened differentiation time F-cell formation is attributed to "premature commitment" of progenitors. gamma-gene expression occurs either because chromatin changes that normally inactivate the gamma genes are not completed or because critical divisions in which the gamma genes are normally inactivated are skipped. The model of faster cycling explains F-cell formation by assuming that gamma-gene transcription is activated when the cycle (and especially the duration of G0/G1) of progenitors or erythroblasts falls below a critical time. The proposed models can readily explain the F-cells of the normal adult as the products of random deviation from normal erythroid kinetics. The two models can also explain F-cell formation in chronic erythropoietic stress (chronic hemolytic anemias, patients with hemoglobinopathies). Differences in the degree of F-cell elevation in such patients may reflect differences in the intensity of kinetic perturbation of their erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409871     DOI: 10.1111/j.1749-6632.1985.tb17188.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

Review 1.  Future prospects for treatment of hemoglobinopathies.

Authors:  J A Stamatoyannopoulos
Journal:  West J Med       Date:  1992-12

Review 2.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

3.  Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation.

Authors:  Rodwell Mabaera; Christine A Richardson; Kristin Johnson; Mei Hsu; Steven Fiering; Christopher H Lowrey
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

4.  Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

Authors:  Yankai Zhang; Alireza Paikari; Pavel Sumazin; Carly C Ginter Summarell; Jacy R Crosby; Eric Boerwinkle; Mitchell J Weiss; Vivien A Sheehan
Journal:  Blood       Date:  2018-06-08       Impact factor: 22.113

5.  To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation?

Authors:  Antonella Ronchi; Sergio Ottolenghi
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

6.  Fetal hemoglobin synthesis in vivo: direct evidence for control at the level of erythroid progenitors.

Authors:  T Umemura; A Al-Khatti; T Papayannopoulou; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 7.  Fetal haemoglobin induction in sickle cell disease.

Authors:  Alireza Paikari; Vivien A Sheehan
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

8.  Serum factors can modulate the developmental clock of gamma- to beta-globin gene switching in somatic cell hybrids.

Authors:  G Zitnik; Q Li; G Stamatoyannopoulos; T Papayannopoulou
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Stage-specific functional roles of integrins in murine erythropoiesis.

Authors:  Tatyana Ulyanova; Steven M Padilla; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2014-01-23       Impact factor: 3.084

10.  A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.

Authors:  Vinod Vathipadiekal; John J Farrell; Shuai Wang; Heather L Edward; Heather Shappell; A M Al-Rubaish; Fahad Al-Muhanna; Z Naserullah; A Alsuliman; Hatem Othman Qutub; Irene Simkin; Lindsay A Farrer; Zhihua Jiang; Hong-Yuan Luo; Shengwen Huang; Gustavo Mostoslavsky; George J Murphy; Pradeep K Patra; David H K Chui; Abdulrahman Alsultan; Amein K Al-Ali; Paola Sebastiani; Martin H Steinberg
Journal:  Am J Hematol       Date:  2016-08-22       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.